A randomized, multi-centric, active controlled, parallel group, open-label, comparative study to evaluate the efficacy and safety of Rabeprazole and Omeprazole in patients of gastroesophageal reflux disease (GERD)
Active, not recruitingPACTR202305577953836
SUN PHARMADigestive System
Start: 2023-12-15Target: 486Updated: 2026-08-03